AtroscineCAS# 138-12-5 |
2D Structure
- Scopolamine
Catalog No.:BCN5045
CAS No.:51-34-3
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 138-12-5 | SDF | Download SDF |
PubChem ID | 6451257 | Appearance | Powder |
Formula | C17H21NO4 | M.Wt | 303.36 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
SMILES | CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4 | ||
Standard InChIKey | STECJAGHUSJQJN-QBMZJCKTSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Atroscine has adrenolytic activity by its ability to antagonize the lethal effect of epinephrine in rats. |
Targets | Adrenergic Receptor |
Atroscine Dilution Calculator
Atroscine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.2964 mL | 16.4821 mL | 32.9641 mL | 65.9283 mL | 82.4103 mL |
5 mM | 0.6593 mL | 3.2964 mL | 6.5928 mL | 13.1857 mL | 16.4821 mL |
10 mM | 0.3296 mL | 1.6482 mL | 3.2964 mL | 6.5928 mL | 8.241 mL |
50 mM | 0.0659 mL | 0.3296 mL | 0.6593 mL | 1.3186 mL | 1.6482 mL |
100 mM | 0.033 mL | 0.1648 mL | 0.3296 mL | 0.6593 mL | 0.8241 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Mozavaptan
Catalog No.:BCC5095
CAS No.:137975-06-5
- Dehydrotolvaptan
Catalog No.:BCC8932
CAS No.:137973-76-3
- CBB1007
Catalog No.:BCC4272
CAS No.:1379573-92-8
- CBB1003
Catalog No.:BCC5524
CAS No.:1379573-88-2
- Arillatose B
Catalog No.:BCN6196
CAS No.:137941-45-8
- ML 239
Catalog No.:BCC3987
CAS No.:1378872-36-6
- 6-O-Feruloylglucose
Catalog No.:BCN6195
CAS No.:137887-25-3
- Valsartan methyl ester
Catalog No.:BCC9189
CAS No.:137863-17-3
- Valsartan
Catalog No.:BCC5017
CAS No.:137862-53-4
- 2,3-Di(3',4'-methylenedioxybenzyl)-2-buten-4-olide
Catalog No.:BCN1576
CAS No.:137809-97-3
- Boeravinone E
Catalog No.:BCN4083
CAS No.:137787-00-9
- 12-O-Acetylrosmarinine
Catalog No.:BCN2125
CAS No.:137760-53-3
- Mafenide
Catalog No.:BCC5237
CAS No.:138-39-6
- D-(-)-Salicin
Catalog No.:BCN6298
CAS No.:138-52-3
- Picrocrocine
Catalog No.:BCC8232
CAS No.:138-55-6
- Shikimic acid
Catalog No.:BCN6200
CAS No.:138-59-0
- Limonene
Catalog No.:BCN3797
CAS No.:138-86-3
- Decorticasine
Catalog No.:BCN2006
CAS No.:1380-03-6
- BET bromodomain inhibitor
Catalog No.:BCC6426
CAS No.:1380087-89-7
- KB SRC 4
Catalog No.:BCC6253
CAS No.:1380088-03-8
- EPZ5676
Catalog No.:BCC2215
CAS No.:1380288-87-8
- EPZ004777 HCl
Catalog No.:BCC4550
CAS No.:1380316-03-9
- Valeriandoid B
Catalog No.:BCN6754
CAS No.:1380399-57-4
- KML 29
Catalog No.:BCC6312
CAS No.:1380424-42-9
Structure-activity requirements for hypotension and alpha-adrenergic receptor blockade by analogues of atropine.[Pubmed:6135619]
Eur J Pharmacol. 1983 May 20;90(1):75-83.
The hypotensive action of various antimuscarinic compounds structurally related to atropine was studied in conscious, unanesthetized rats. The alpha-adrenolytic activity of these agents was assessed both in vivo (blockade of norepinephrine-induced pressor response) and in vitro (displacement of [3H]WB-4101 binding). Benztropine, homatropine and hyoscyamine caused hypotension and produced alpha-adrenergic receptor blockade similar to atropine. Other analogues were either inactive (Atroscine, scopolamine, tropic acid and tropine) or evoked nonspecific changes in blood pressure and lacked alpha-adrenolytic activity (benactyzine, eucatropine, methylatropine, methylhomatropine and methylscopolamine). Based on these data, we propose the following structure-activity relationship for hypotension and alpha-adrenolytic activity: (a) the tropine moiety is inactive unless it is attached to another group by an ester linkage, (b) chemical modification of the tropine moiety, including quaternization, decreases potency, (c) the d-stereoisomer appears to be more potent than the corresponding 1-form.